Hyperrho S/d Full Dose

  • Immune-mediated blood disorders

Hyperrho S/d Full Dose Generic Name & Formulations

General Description

Rho(D) immune globulin human 1500 IU; per syringe; soln for IM inj; preservative-free; latex-free.

Pharmacological Class

Immune globulin.

How Supplied

Full dose (Single-dose prefilled syringe)—1; Mini dose (Single-dose prefilled syringe)—10

Hyperrho S/d Full Dose Indications


Prevention of isoimmunization in non-sensitized Rho(D) negative women during pregnancy and in appropriate obstetrical conditions, unless the fetus or father is known to be Rho(D) negative. Prevention of isoimmunization in Rho(D) negative individuals transfused with Rho(D) positive blood products.

Hyperrho S/d Full Dose Dosage and Administration


See literature. Give IM only. Pregnancy (28 weeks gestation), postpartum prophylaxis (within 72 hours), obstetric complications, invasive procedures during pregnancy: 1500IU. Incompatible transfusions (within 72 hours): volume of red blood cells transfused divided by 15mL provides the number of syringes to be administered; if the dose is a fraction, round to next higher whole number of syringes.


Not recommended.

Hyperrho S/d Full Dose Contraindications



Hyperrho S/d Full Dose Boxed Warnings

Not Applicable

Hyperrho S/d Full Dose Warnings/Precautions


Contains human plasma; monitor for possible infection transmission. IgA deficiency. Pregnancy (Cat.C).

Hyperrho S/d Full Dose Pharmacokinetics

See Literature

Hyperrho S/d Full Dose Interactions


Avoid live vaccines within 3 months.

Hyperrho S/d Full Dose Adverse Reactions

Adverse Reactions

Local or infusion reactions.

Hyperrho S/d Full Dose Clinical Trials

See Literature

Hyperrho S/d Full Dose Note


Report all infections suspected to be transmitted by HyperRHO S/D to (800) 520-2807.

Hyperrho S/d Full Dose Patient Counseling

See Literature